Quadrant Capital Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-175
| Closed | -$2K | – | 2535 |
|
|
2022
Q1 | $2K | Sell |
175
-27
| -13% | -$309 | ﹤0.01% | 2127 |
|
|
2021
Q4 | $3K | Sell |
202
-16
| -7% | -$238 | ﹤0.01% | 2004 |
|
|
2021
Q3 | $10K | Buy |
218
+5
| +2% | +$229 | ﹤0.01% | 1569 |
|
|
2021
Q2 | $13K | Buy |
213
+2
| +0.9% | +$122 | ﹤0.01% | 1421 |
|
|
2021
Q1 | $13K | Buy |
211
+14
| +7% | +$863 | ﹤0.01% | 1373 |
|
|
2020
Q4 | $14K | Hold |
197
| – | – | ﹤0.01% | 1223 |
|
|
2020
Q3 | $7K | Hold |
197
| – | – | ﹤0.01% | 1358 |
|
|
2020
Q2 | $6K | Buy |
+197
| New | +$6K | ﹤0.01% | 1551 |
|